 |
|
|
|
|
|
|
Bourgeois P, et al.
Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo.
Osteoarthritis Cartilage. 1998 May;6 Suppl A:25-30.
|
|
Bucsi L, et al.
Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis.
Osteoarthritis Cartilage. 1998 May;6 Suppl A:31-6.
|
|
Gross,D.
Orale chondroitinsulfatmedikation zur behandlung von arthrosen [Oral chondroitin sulfate medication for the treatment of osteoarthritis].
Therapiewoche. 1983;33: 4238-4244.
|
|
L'Hirondel JL.
Kinische doppelblind-studie mit oral verabreichtem chondroitin-sulfat gegen placebo bei der tibiofemoralen gonarthose (125 patienten).
Litera Rheum 1992;14:77-85.
|
|
Mazieres B, et al.
[Chondroitin sulfate in the treatment of gonarthrosis and coxarthrosis. 5-months result of a multicenter double-blind controlled prospective study using placebo]
Rev Rhum Mal Osteoartic. 1992 Jul-Sep;59(7-8):466-72. French.
|
|
Mazieres B, et al.
Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study.
J Rheumatol. 2001 Jan;28(1):173-81.
|
|
Morreale P, et al.
Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis.
J Rheumatol. 1996 Aug;23(8):1385-91.
|
|
Pavelka K, Busci L, Manopulo R.
Double-blind dose effect study of oral CS 4&6 1200 mg, 800 mg, 200 mg against placebo in the treatment of femorotibial osteoarthritis.
Litera Rheum 1999;24:21-30.
|
|
Rovetta G, et al.
Chondroitin sulfate in erosive osteoarthritis of the hands.
Int J Tissue React. 2002;24(1):29-32.
|
|
Rovetta G, et al.
A two-year study of chondroitin sulfate in erosive osteoarthritis of the hands: behavior of erosions, osteophytes, pain and hand dysfunction.
Drugs Exp Clin Res. 2004;30(1):11-6.
|
|
Uebelhart D, et al.
Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.
Osteoarthritis Cartilage. 2004 Apr;12(4):269-76.
|
|
Uebelhart D, et al.
Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study.
Osteoarthritis Cartilage 1998;6(suppl A):39-46.
|
|
Verbruggen G, et al.
Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.
Osteoarthritis Cartilage. 1998 May;6 Suppl A:37-8.
|
Back to Top |
|
|
|
|
|
|
 |
GAIT Study |
|
|
|
|
GUIDE Study |
|
|
|
|
 |
|
Who Owns This Joint?
by David A. Mark, Ph.D. |
|
|
David A. Mark, Ph.D. is President of dmark consulting LLC, a firm specializing in research management services for the functional food, food ingredient, dietary supplement and performance nutrition industries.
Read more about David A. Mark, Ph.D. |
|
|
|
|
